June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Nicotinamide and its role in reducing complement activation and oxidative stress in age-related macular degeneration
Author Affiliations & Notes
  • Karolina Ploessl
    Institute of Human Genetics, Universität Regensburg, Universitat Regensburg, Regensburg, Bayern, DE, academic, Germany
  • Anna Eifler
    Institute of Human Genetics, Universität Regensburg, Universitat Regensburg, Regensburg, Bayern, DE, academic, Germany
  • Ardita Ramadani
    Institute of Human Genetics, Universität Regensburg, Universitat Regensburg, Regensburg, Bayern, DE, academic, Germany
  • Florian Schaetzler
    Institute of Human Genetics, Universität Regensburg, Universitat Regensburg, Regensburg, Bayern, DE, academic, Germany
  • Bernhard HF Weber
    Institute of Human Genetics, Universität Regensburg, Universitat Regensburg, Regensburg, Bayern, DE, academic, Germany
    Insitute of Clinical Human Genetics, Universitatsklinikum Regensburg, Regensburg, Bayern, Germany
  • Footnotes
    Commercial Relationships   Karolina Ploessl None; Anna Eifler None; Ardita Ramadani None; Florian Schaetzler None; Bernhard Weber None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 469 – A0006. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karolina Ploessl, Anna Eifler, Ardita Ramadani, Florian Schaetzler, Bernhard HF Weber; Nicotinamide and its role in reducing complement activation and oxidative stress in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2022;63(7):469 – A0006.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent work suggests that the vitamin B3 derivative nicotinamide (NA) ameliorates an age-related macular degeneration (AMD) phenotype in retinal pigment epithelium (RPE) cells derived from induced pluripotent stem cells (iPSCs) (Saini et al., 2018). While NA is a frequent supplement in RPE culture media for its property to enhance iPSC-RPE differentiation, it may inadvertently disguise molecular phenotypes in cellular models of RPE pathologies. We therefore aimed to investigate the effects of NA depletion on RPE cell integrity and functionality as well as oxidative stress susceptibility in iPSC-RPE cell lines categorized into extremes of high or low genetic risk for AMD.

Methods : iPSC-RPE cells were cultivated on transwell inserts and depleted of NA one week after seeding. Oxidative stress was induced by sodium iodate (SI) treatment. RPE cell layer integrity and functionality was analyzed by transepithelial resistance (TEER) measurements, immunocytochemistry and a photoreceptor outer segment (POS) phagocytosis assay. mRNA expression of markers for RPE cell faith, complement cascade and oxidative stress response was measured by qRT-PCR and verified by Western Blot and ELISA.

Results : NA depletion had no influence on RPE monolayer integrity as shown by immunocytochemistry and TEER measurement. Upon NA depletion RPE markers BEST1 and RPE65 were down regulated, whereas expression of complement markers CFH and C3 and oxidative stress markers HMOX1 and NQO1 were increased. These changes were reversible by reintroducing NA. Intriguingly, cells depleted of NA showed an increased uptake of POS. Oxidative stress was induced by SI treatment. Cells depleted of NA did not show a more pronounced stress response than cells cultivated in presence of NA. Cell lines with different genetic AMD risk scores did not show differences for any of the parameters addressed.

Conclusions : While NA decreases baseline expression of oxidative stress response and complement cascade marker genes in iPSC-RPE the cellular responses to SI mediated oxidative stress remain unmodified. Additionally, RPE cells depleted of NA showed a much higher POS phagocytosis than cells cultivated with NA. It thus remains elusive if the beneficial effect of NA on oxidative stress and complement regulation makes it a suitable therapeutic agent for AMD.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×